Heparininduceret trombocytopeni

Christina Christoffersen, Stefan Lethagen, Jens Peter Gøtze


Heparin treatment can cause an immune-mediated thrombocytopenia: HIT. HIT antibodies can be detected by various methods, but laboratory analyses are not specific or sensitive and may delay the diagnostic process. It is therefore important to initiate alternative treatment based on the clinical findings, and a clinical score system for evaluating the risk of HIT has been suggested. When HIT is likely, treatment consists of immediate replacement of heparin with alternative anticoagulation treatment and refrainment from warfarin therapy and platelet infusion.

Bidragets oversatte titelHeparin-induced thrombocytopenia
TidsskriftUgeskrift for Laeger
Udgave nummer8
Sider (fra-til)612-5
Antal sider4
StatusUdgivet - 16 feb. 2009
Udgivet eksterntJa


  • Anticoagulants/adverse effects
  • Arginine/analogs & derivatives
  • Chondroitin Sulfates/therapeutic use
  • Dermatan Sulfate/therapeutic use
  • Fibrinolytic Agents/adverse effects
  • Heparin/adverse effects
  • Heparitin Sulfate/therapeutic use
  • Hirudins
  • Humans
  • Pipecolic Acids/therapeutic use
  • Recombinant Proteins/therapeutic use
  • Risk Factors
  • Sulfonamides
  • Thrombocytopenia/chemically induced


Dyk ned i forskningsemnerne om 'Heparininduceret trombocytopeni'. Sammen danner de et unikt fingeraftryk.